Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Taniguchi, Shuichi  [Clear All Filters]
2024
Yamaguchi K, Yamamoto H, Izutsu K, Yuasa M, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, et al. Fatal outcome of BK virus encephalitis in an allogeneic stem cell transplantation recipient. J Infect Chemother. 2024.
2023
Shimizu Y, Kaji D, Watanabe O, Yamaguchi K, Kageyama K, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto H, et al. Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective study. Cancer Med. 2023.
2022
Oyama T, Kageyama K, Araoka H, Mitsuki T, Yamaguchi K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, et al. Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients. Int J Hematol. 2022.
Kimura M, Asano-Mori Y, Sakoh T, Abe M, Ueno K, Hoshino Y, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, et al. Factors associated with breakthrough fungemia caused by , , or species when the breakthrough fungemia developed in patients with hematological disorders. Antimicrob Agents Chemother. 2022:AAC0208121.
Taniguchi S, Utsumi S, Kochi Y, Taya Y, Mori Y, Semba Y-I, Sugio T, Miyawaki K, Kikushige Y, Kunisaki Y, et al. Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation. Int J Hematol. 2022.
2021
Yamamuro R, Kimura M, Asano-Mori Y, Abe M, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, Ogura S, Sakoh T, et al. Clinical and microbiological characteristics of proven invasive aspergillosis due to rare/cryptic species in allogeneic hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother. 2021:AAC0163021.
Nomura K, Iizuka T, Kaji D, Asano-Mori Y, Ochiai Y, Suzuki Y, Hayasaka J, Yamashita S, Matsui A, Kikuchi D, et al. Secondary esophageal squamous cell carcinoma after hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2021.
2020
Yuasa M, Yamamoto H, Mitsuki T, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto G, et al. Prognostic impact of cytogenetic evolution on the outcome of allogeneic stem cell transplantation in patients with acute myeloid leukemia in non-remission: A single institute analysis of 212 recipients. Biol Blood Marrow Transplant. 2020.
2015
Sugita J, Kawashima N, Fujisaki T, Kakihana K, Ota S, Matsuo K, Miyamoto T, Akashi K, Taniguchi S, Harada M, et al. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide following Busulfan-containing Reduced-Intensity Conditioning. Biol Blood Marrow Transplant. 2015.
2014
Takagi S, Araoka H, Uchida N, Uchida Y, Kaji D, Ota H, Nishida A, Ishiwata K, Tsuji M, Yamamoto H, et al. A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning. Int J Hematol. 2014.
Kato K, Choi I, Wake A, Uike N, Taniguchi S, Moriuchi Y, Miyazaki Y, Nakamae H, Oku E, Murata M, et al. Treatment of adult T-cell leukemia/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey. Biol Blood Marrow Transplant. 2014.
2013
Eto T, Takase K, Miyamoto T, Ohno Y, Kamimura T, Nagafuji K, Takamatsu Y, Teshima T, Gondo H, Taniguchi S, et al. Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission. Int J Hematol. 2013.